MX2022015593A - Metodo de ensamblaje de particulas similares a virus de dos componentes. - Google Patents

Metodo de ensamblaje de particulas similares a virus de dos componentes.

Info

Publication number
MX2022015593A
MX2022015593A MX2022015593A MX2022015593A MX2022015593A MX 2022015593 A MX2022015593 A MX 2022015593A MX 2022015593 A MX2022015593 A MX 2022015593A MX 2022015593 A MX2022015593 A MX 2022015593A MX 2022015593 A MX2022015593 A MX 2022015593A
Authority
MX
Mexico
Prior art keywords
protein
compb
compa
inlet fluid
fluid stream
Prior art date
Application number
MX2022015593A
Other languages
English (en)
Inventor
Charles Richardson
Hans R Lien
Scot R Shepard
Ross M Taylor
Original Assignee
Icosavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icosavax Inc filed Critical Icosavax Inc
Publication of MX2022015593A publication Critical patent/MX2022015593A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18523Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analytical Chemistry (AREA)

Abstract

En la presente se divulgan métodos para elaborar una nanoestructura, que comprende agregar una proteína de componente A (compA) a una solución que comprende una proteína de componente B (compB) en condiciones que minimizan la tensión de cizallamiento, que forma así un complejo compA:compB. Adicionalmente, se divulgan métodos para elaborar una nanoestructura, que comprende (i) proporcionar una primera corriente de fluido de entrada que comprende una primera proteína y una segunda corriente de fluido de entrada que comprende una segunda proteína, y (ii) poner en contacto la primera corriente de fluido de entrada y la segunda corriente de fluido de entrada para formar una corriente de salida, en donde la mezcla de la primera proteína y la segunda proteína se produce en la corriente de salida, que forma así un complejo de proteínas comprende la primera proteína y la segunda proteína. Se puede utilizar un mezclador microfluídico. Los métodos pueden comprender además purificar el complejo compA:compB del exceso de compA, exceso de compB y/u otras impurezas al filtrar la solución con una membrana de 1,000 kDa o un equivalente de esta.
MX2022015593A 2020-06-09 2021-06-09 Metodo de ensamblaje de particulas similares a virus de dos componentes. MX2022015593A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063036505P 2020-06-09 2020-06-09
PCT/US2021/036689 WO2021252688A1 (en) 2020-06-09 2021-06-09 Method of assemblying two-component virus-like particle

Publications (1)

Publication Number Publication Date
MX2022015593A true MX2022015593A (es) 2023-04-03

Family

ID=78846601

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022015593A MX2022015593A (es) 2020-06-09 2021-06-09 Metodo de ensamblaje de particulas similares a virus de dos componentes.

Country Status (9)

Country Link
US (1) US20230227790A1 (es)
EP (1) EP4161949A1 (es)
JP (1) JP2023530635A (es)
KR (1) KR20230038465A (es)
CN (1) CN116234567A (es)
AU (1) AU2021289470A1 (es)
CA (1) CA3182021A1 (es)
MX (1) MX2022015593A (es)
WO (1) WO2021252688A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023225562A1 (en) * 2022-05-17 2023-11-23 Icosavax, Inc. Multivalent vaccine for paramyxoviruses and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140335148A1 (en) * 2013-05-07 2014-11-13 Ho-Wang Tong Bioactive substance-containing nanofibers and uses thereof
WO2018006166A1 (en) * 2016-07-06 2018-01-11 Precision Nanosystems Inc Smart microfluidic mixing instrument and cartridges
JP7168938B2 (ja) * 2017-04-04 2022-11-10 ユニヴァーシティ オブ ワシントン パラミクソウイルスおよび/またはニューモウイルスのfタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用

Also Published As

Publication number Publication date
WO2021252688A1 (en) 2021-12-16
JP2023530635A (ja) 2023-07-19
AU2021289470A1 (en) 2023-01-19
CN116234567A (zh) 2023-06-06
EP4161949A1 (en) 2023-04-12
US20230227790A1 (en) 2023-07-20
KR20230038465A (ko) 2023-03-20
CA3182021A1 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
He et al. Application of microfluidic technology in food processing
Corbatón-Báguena et al. Evaluation of fouling resistances during the ultrafiltration of whey model solutions
MX2022015593A (es) Metodo de ensamblaje de particulas similares a virus de dos componentes.
ATE489178T1 (de) System und verfahren zur behandlung von flugasche
WO2007128795A3 (en) Method for separation
DE17203101T1 (de) Fraktionierungsverfahren von löslichen Substanzen von Erbsen
CA2956687C (en) Flocculation
CN103992402A (zh) 一种高纯度藻蓝蛋白的制备方法
DE602004025773D1 (de) Verfahren zur Verarbeitung von Fleisch
AU2016276972A8 (en) Methods and systems for extracting protein and carbohydrate rich products from a microcrop and compositions thereof
PH12019500446A1 (en) Epoxy emulsion and preparation method therefor
Ullah et al. Stability and deformation of oil droplets during microfiltration on a slotted pore membrane
MX2021000866A (es) Sistemas y metodos para la filtracion de flujo tangencial de composiciones viscosas.
CN108779145A (zh) 用于浓缩生物分子溶液的切向流过滤方法
Liu et al. Recovery of soluble proteins from Chlorella vulgaris by bead-milling and microfiltration: Impact of the concentration and the physicochemical conditions during the cell disruption on the whole process
Balti et al. Fractionation of Arthrospira platensis (Spirulina) water soluble proteins by membrane diafiltration
ATE405591T1 (de) Kontinuierliches verfahren zur anordnung von makromolekulären substanzen und die anschliessende aufnahme und isolierung einer makromolekulären anordnung, sowie ein für dieses verfahren geeignetes system
CN109700036B (zh) 一种内聚性提高的高蛋白营养棒及其制备方法
EP3161136B1 (de) Verfahren zur anreicherung von mikrovesikeln
EP2242339A3 (de) Gasinjektionssystem und Verfahren zum Betrieb eines Gasinjektionssystems, insbesondere für eine Partikeltherapieanlage
Cheetangdee et al. Protein stabilized oil-in-water emulsions modified by uniformity of size by premix membrane extrusion and their colloidal stability
EP2275891A3 (de) Ventileinrichtung
Bacchin Interfacially driven transport in narrow channels
Sari et al. Isolation and purification of Bromelain from pineapple core (Ananas comosus [L]. Merr) by ammonium sulfate and ethanol precipitation
Köhlera et al. Homogenisation in the dairy process-conventional processes and novel techniques